National Pharmacology Directors of Graduate Programs Meeting

全国研究生项目药理学主任会议

• 批准号: 7675163
• 负责人: Joey V. Barnett
• 金额: $ 0.6万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-03-01 至 2010-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7675163
• 关键词: Academia; Address; Animals; Cell physiology; Clinic; Discipline; Disease; Doctor of Philosophy; Drug Kinetics; Drug effect disorder; Education; Face; Goals; Government; Human; Human Biology; Industry; Knowledge; Laboratories; Molecular; Outcome; Patient Care; Pharmacology; Pharmacotherapy; Science; Scientist; Shapes; Students; Systems Biology; Training; Training Programs; design; drug metabolism; human disease; improved; insight; interest; meetings; programs; public health relevance; response

DESCRIPTION (provided by applicant): The integration of our scientific knowledge at the molecular, cellular, and organismal levels is critical to impacting disease in humans. As our insight into molecular and cellular processes has grown, emphasis in many Ph.D. training programs has shifted away from integrated (whole animal or systems) biology, including the biology of humans. The lack of an available scientific workforce with an understanding of integrated or human biology, including drug metabolism and pharmacokinetics, and an appreciation of the unique challenges of converting discoveries into therapies will delay the application of discoveries at the molecular and cellular levels to human disease. Scientists trained in the discipline of Pharmacology form an important part of this necessary workforce. This meeting addresses critical issues related to training Pharmacologists and has been planned in response to a perceived and real decline in training programs. The goals of this meeting are to identify common problems and opportunities that face Ph.D. training programs in Pharmacology and to discuss how best to meet them. The target audience for this meeting is Directors of Graduate Training Programs in Pharmacology or other biomedical sciences. This meeting will provide a unique opportunity for these scientists to exchange information and to interact with leaders in industry, government, and academia who help shape this discipline. A continuing dialogue among Directors of training programs and other scientists with an interest in training is identified as a desired major outcome. PUBLIC HEALTH RELEVANCE: Pharmacology is the scientific discipline that studies the actions of drugs and is dedicated to the design of new drugs and therapies that move scientific discoveries from the laboratory into the clinic. This meeting is the only meeting for directors of pharmacology training programs that is dedicated to improving the education of students in pharmacology programs. Efforts resulting from this meeting will result in an increase in both the quality and quantity of students trained in pharmacology and will aid in the transfer of scientific knowledge to patient care.

描述(由申请人提供)：我们在分子、细胞和生物体水平上的科学知识的整合对影响人类疾病至关重要。随着我们对分子和细胞过程的洞察力不断增强，许多博士培训项目的重点已经从整合(整个动物或系统)生物学，包括人类生物学转向。缺乏一支了解综合生物学或人类生物学(包括药物代谢和药代动力学)的现有科学队伍，以及认识到将发现转化为治疗的独特挑战，将推迟在分子和细胞层面上将发现应用于人类疾病。受过药理学训练的科学家构成了这一必要劳动力的重要组成部分。这次会议解决了与培训药剂师相关的关键问题，并已针对培训计划明显和实际下降的情况进行了计划。本次会议的目标是确定药理学博士培训计划面临的共同问题和机会，并讨论如何最好地满足这些问题。本次会议的目标受众是药理学或其他生物医学领域的研究生培训项目主任。这次会议将为这些科学家提供一个独特的机会，让他们交流信息，并与帮助形成这一学科的工业界、政府和学术界的领导人互动。培训方案主任和其他对培训感兴趣的科学家之间的持续对话被确定为预期的主要成果。 公共卫生相关性：药理学是研究药物作用的科学学科，致力于设计将科学发现从实验室转移到临床的新药和疗法。这次会议是唯一一次致力于改善药理学专业学生教育的药理学培训项目负责人会议。这次会议产生的努力将导致药理学培训的学生的质量和数量的增加，并将有助于将科学知识转移到病人护理中。